RIGGS STEVEN

SEC source: 0001189724-18-000004 · edgardoc.xml · derivative · entry 3

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,355 shares

Expires 2018-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

SEC source: 0001189724-18-000004 · edgardoc.xml · nonDerivative · entry 2

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,127

SEC source: 0001189724-18-000004 · edgardoc.xml · nonDerivative · entry 1

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,596

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0001189724-18-000002 · edgardoc.xml · derivative · entry 3

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 835

Underlying: Common Stock · 834 shares

Expires 2019-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

SEC source: 0001189724-18-000002 · edgardoc.xml · nonDerivative · entry 2

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,241

SEC source: 0001189724-18-000002 · edgardoc.xml · nonDerivative · entry 1

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,555

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0001189724-17-000004 · edgardoc.xml · derivative · entry 2

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,374

Underlying: Common Stock · 1,374 shares

Expires 2020-03-27

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F5 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

SEC source: 0001189724-17-000004 · edgardoc.xml · derivative · entry 1

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,374

Underlying: Common Stock · 1,374 shares

Expires 2019-12-31

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · date: The executive officers were notified of their awards by the Registrant on March 30, 2017.

F2 · price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F4 · derivative.exercise_date: The vesting for this performance-based restricted stock unit ("PRSU") award is dependent upon the reporting person's earning PRSUs based on the achievement of performance criteria related to the Company's fiscal year 2019 Cumulative Adjusted EBITDA in comparison to the fiscal year 2016 Adjusted EBITDA. The number of shares reported is the target award amount. The reporting person may potentially earn PRSUs ranging from 100% to 300% of the target award amount.

SEC source: 0001189724-17-000003 · edgardoc.xml · derivative · entry 8

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,250

Underlying: Common Stock · 15,000 shares

Expires 2024-02-24

F7 · price: Transaction is the exercise of a derivative security; see Column 2.

F6 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days.

SEC source: 0001189724-17-000003 · edgardoc.xml · derivative · entry 7

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,250

Underlying: Common Stock · 16,250 shares

Expires 2024-02-24

F7 · price: Transaction is the exercise of a derivative security; see Column 2.

F6 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days.

SEC source: 0001189724-17-000003 · edgardoc.xml · nonDerivative · entry 6

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,326

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.95 to $152.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189724-17-000003 · edgardoc.xml · nonDerivative · entry 5

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,530

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.95 to $151.90, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189724-17-000003 · edgardoc.xml · nonDerivative · entry 4

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,326

SEC source: 0001189724-17-000003 · edgardoc.xml · nonDerivative · entry 3

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,326

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.95 to $152.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189724-17-000003 · edgardoc.xml · nonDerivative · entry 2

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,076

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.95 to $151.90, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189724-17-000003 · edgardoc.xml · nonDerivative · entry 1

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,576

SEC source: 0001189724-17-000002 · edgardoc.xml · derivative · entry 3

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,355

Underlying: Common Stock · 1,354 shares

Expires 2018-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

SEC source: 0001189724-17-000002 · edgardoc.xml · nonDerivative · entry 2

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,326

SEC source: 0001189724-17-000002 · edgardoc.xml · nonDerivative · entry 1

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,833

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0001189724-17-000001 · edgardoc.xml · derivative · entry 3

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,669

Underlying: Common Stock · 834 shares

Expires 2019-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units.

F3 · derivative.exercise_date: One third of the Units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.

SEC source: 0001189724-17-000001 · edgardoc.xml · nonDerivative · entry 2

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 479

SEC source: 0001189724-17-000001 · edgardoc.xml · nonDerivative · entry 1

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 834

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities are Restricted Stock Units.

SEC source: 0001189724-16-000017 · edgardoc.xml · derivative · entry 21

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Common Stock · 1,677 shares

Expires 2024-02-24

F15 · price: Transaction is the exercise of a derivative security; see Column 2.

F14 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days.

SEC source: 0001189724-16-000017 · edgardoc.xml · derivative · entry 20

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,177

Underlying: Common Stock · 800 shares

Expires 2024-02-24

F15 · price: Transaction is the exercise of a derivative security; see Column 2.

F14 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days.

SEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 16

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016.

F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.87 to $122.19, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 15

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,677

SEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 14

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016.

F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.75 to $122.13, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 13

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 800

SEC source: 0001189724-16-000017 · edgardoc.xml · derivative · entry 22

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,446

Underlying: Common Stock · 2,460 shares

Expires 2023-02-06

F15 · price: Transaction is the exercise of a derivative security; see Column 2.

F16 · derivative.exercise_date: Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.

SEC source: 0001189724-16-000017 · edgardoc.xml · derivative · entry 19

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,977

Underlying: Common Stock · 11,957 shares

Expires 2024-02-24

F15 · price: Transaction is the exercise of a derivative security; see Column 2.

F14 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days.

SEC source: 0001189724-16-000017 · edgardoc.xml · derivative · entry 18

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,934

Underlying: Common Stock · 12,833 shares

Expires 2024-02-24

F15 · price: Transaction is the exercise of a derivative security; see Column 2.

F14 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days.

SEC source: 0001189724-16-000017 · edgardoc.xml · derivative · entry 17

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,767

Underlying: Common Stock · 13,634 shares

Expires 2024-02-24

F15 · price: Transaction is the exercise of a derivative security; see Column 2.

F14 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days.

SEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 12

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016.

F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.99 to $122.18, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 11

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,700

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016.

F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.97 to $121.96, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 10

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,417

SEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 9

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,957

SEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 8

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.04 to $122.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 7

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.04 to $122.03, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 6

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,833

SEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 5

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.00 to $122.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 4

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,384

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.00 to $121.99, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 3

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,634

SEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 2

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F4 · security: These securities are Restricted Stock Units.

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.14 to $121.70, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC source: 0001189724-16-000017 · edgardoc.xml · nonDerivative · entry 1

RIGGS STEVEN · CIK 0001189724 · VP Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 675

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on August 11, 2016.

F2 · shares: Shares purchased through Employee Stock Purchase Plan.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.14 to $121.31, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.